Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO) [Phase 1, Phase 2]
Clinical trial update for PIQHASSO evaluating PQR309 and eribulin in metastatic breast cancer across phase 1 and phase 2 (completed).
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery [Phase 1, Phase 2]
A clinical trial update for TAHP in HER2-positive breast cancer undergoing adjuvant therapy after surgery, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: High Dose Vitamin D vs Standard Dose Vitamin D Study [Phase 2]
Phase 2 trial comparing high-dose versus standard-dose vitamin D in breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation [Phase 2]
Phase 2 trial investigating pembrolizumab in combination with tamoxifen for advanced hormone receptor-positive breast cancer with ESR1 mutat…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC [Phase 2]
Phase 2 clinical trial evaluating pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer [Phase 1]
Phase 1 trial evaluating PF-03084014 in combination with docetaxel in advanced/metastatic breast cancer; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating Herceptin for efficacy in HER2-negative breast cancer with circulating tumor cells.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) [Phase 3]
The document provides an update on the Phase 3 TAILORx trial evaluating whether adding combination chemotherapy to hormone therapy improves …
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating cyclophosphamide and vaccine therapy with or without trastuzumab in metastatic breast cancer; study completed with …
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating NEPA to prevent chemotherapy-induced nausea and vomiting in breast cancer patients (completed).
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab and pertuzumab or bevacizumab with combination chemotherapy in stage II–III breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating Arimidex with or without Faslodex in postmenopausal women with HR-positive breast cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel [Phase 2]
Phase 2 biomarker study in HER2-negative metastatic breast cancer treated with bevacizumab and paclitaxel has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer [Phase 1, Phase 2]
Open-label dose-finding study evaluating TRC105 in combination with capecitabine for metastatic breast cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: BREAST CANCER AND EXERCISE [Phase 3]
Phase 3 trial update investigating exercise in breast cancer patients, focusing on osteoporosis prevention, quality of life, physical fitnes…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of oral Navelbine in HER2-negative metastatic breast cancer in female patients.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer [Phase 3]
A Phase 3 trial evaluating efficacy and safety in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer h…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT) [NA]
Clinical trial assessing diagnostic accuracy of digital breast tomosynthesis vs mammography for breast cancer detection; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Increasing Physical Activity Among Breast Cancer Survivors With Depression [NA]
A trial evaluating increasing physical activity among breast cancer survivors with depression has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients [NA]
This clinical trial update shows that the study of Somnage® for sleep and mood in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: A Pilot Study - Comparison of Two Hologic 3D Mammography Systems
A pilot study comparing two Hologic 3D mammography systems has been completed to evaluate imaging performance for breast cancer screening.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours [Phase 2]
A Phase 2 trial of capecitabine plus radiotherapy for locally relapsed HER2-negative breast cancer. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: APBI: 27Gy in 5 Fractions for Early Breast Cancer [NA]
This update covers a trial of accelerated partial breast irradiation (APBI) delivering 27 Gy in 5 fractions for early breast cancer. The cur…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: A Sustainable Approach to Increasing Cancer Screening [NA]
A Harvard School of Public Health-led clinical trial on sustainable strategies to increase cancer screening has completed. The study address…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen [Phase 2]
A Phase 2 clinical trial evaluated red clover and lifestyle changes to alleviate menopausal symptoms in premenopausal breast cancer patients…